Clinical Trials · NCT07557953
A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 120
- Start date
- Apr 2026
- Locations
- 1 site, Germany
- Primary endpoint
- Relative change in total energy intake across ad libitum breakfast, lunch, evening meal and snack box